Metro Atlanta has an extraordinary depth of resources centered on the research and development of vaccines. Not only does the region have the world’s foremost eminent scholar in vaccine development, but a variety of public organizations and private companies collaborate closely on the research and development of vaccines.
The Emory Vaccine Center is one of the largest vaccine centers in the world, renowned for its expertise in cellular immunity and immune memory. Areas of research include HIV/AIDS, malaria, basic immunology/virology, cancer and biodefense pathogens. An affiliated translational/clinical arm, The Hope Clinic, conducts innovative, community-based, scientifically grounded human clinical trials of new vaccines and is a member of the prestigious HIV Vaccine Trials Network of the National Institutes of Health (NIH).
Emory University and the University of Georgia collaborate on the Influenza Pathogenesis & Immunology Research Center, one of six national Centers of Excellence for Influenza Research and Surveillance funded by NIH/National Institute of Allergy and Infectious Diseases (NIAID). Emory’s Vaccine and Treatment Evaluation Unit is one of eight NIH/NIAID-funded VTEUs across the country that perform Phase 1, Phase 2, Phase 3 and Phase 4 clinical trials.
The metro area benefits from the presence of the Centers for Disease Control and Prevention (CDC) in Atlanta. The CDC’s Advisory Committee on Immunization Practices (ACIP) can be instrumental in getting a company’s vaccine on the recommended vaccination schedule. The organization continuously produces vaccine-related technologies which can be licensed for commercialization.